The contribution of drugs and toxins to understanding of cholinergic function. [PDF]
, 1990 Whittaker, V.
core +1 more source
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala [PDF]
, 2016 Steven L. Miller +6 more
openalex +1 more source
Structural Mechanism of an Efficacy Photoswitch Targeting the β2‐adrenergic Receptor
Angewandte Chemie International Edition, Volume 65, Issue 18, 27 April 2026.Time‐resolved structures from x‐ray free‐electron laser measurements combined with cellular assays demonstrate how the photoswitchable β‐blocker photoazolol‐1 acts as an efficacy switch of β2‐adrenergic receptor function. Light‐induced ligand repositioning shifts activity from inverse agonism toward neutral antagonism by altering local helical ...
Robin Stipp +29 more
wiley +1 more source
The muscarinic M1-receptor-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients [PDF]
, 1993 D. Ukena +4 more
openalex +1 more source
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same? [PDF]
Tuberc Respir Dis (Seoul), 2018 Miravitlles M +3 more
europepmc +1 more source
Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial [PDF]
, 2015 Claire Ambery +4 more
openalex +1 more source
Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma? [PDF]
Eur Respir Rev, 2016 Busse WW, Dahl R, Jenkins C, Cruz AA.
europepmc +1 more source